|
Tenalisib
|
DB15295 |
[Tenalisib is under investigation in clinical trial NCT03711604 (Compassionate Use Study of Tenalisib (RP6530)).] |
|
Ontamalimab
|
DB15298 |
[Ontamalimab is under investigation in clinical trial NCT03627091 (Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)).] |
|
Petesicatib
|
DB15297 |
[Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).] |
|
Foliglurax
|
DB15292 |
[Foliglurax is under investigation in clinical trial NCT02639221 (A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects).] |
|
BMS-986142
|
DB15291 |
[BMS-986142 is under investigation in clinical trial NCT02880670 (Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects).] |
|
SB-1578
|
DB15294 |
[SB-1578 is under investigation in clinical trial NCT01235871 (A Single and Multiple-Dose Study of SB1578).] |
|
Epalrestat
|
DB15293 |
[Epalrestat is under investigation in clinical trial NCT03244358 (Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer).] |
|
Pegteograstim
|
DB15290 |
[Pegteograstim is under investigation in clinical trial NCT02787876 (Pegteograstim in Children With Solid Tumors).] |
|
2',4,4'-Trihydroxychalcone
|
DB03285 |
|
|
C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
|
DB03286 |
|
|
beta-L-fucose
|
DB03283 |
|
|
2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid
|
DB03284 |
|
|
2'-Deoxymaltose
|
DB03281 |
|
|
p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate
|
DB03280 |
|
|
Lesinidase alfa
|
DB15267 |
[Lesinidase alfa is under investigation in clinical trial NCT02324049 (Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)).] |
|
TAK-580
|
DB15266 |
[TAK-580 is under investigation in clinical trial NCT02723006 (Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma).] |
|
ALK-4290
|
DB15269 |
[ALK-4290 is under investigation in clinical trial NCT03558061 (Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration).] |
|
Afabicin
|
DB15268 |
[Afabicin is under investigation in clinical trial NCT03723551 (Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus).] |
|
Thyrotropin
|
DB15263 |
[Thyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor in Human Myometrium).] |
|
Futuximab
|
DB15262 |
[Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).] |
